# Islet Transplantation in Type 1 Diabetic Kidney Allograft

> **NCT01241864** · PHASE2 · RECRUITING · sponsor: **University of Chicago** · enrollment: 10 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **BIOLOGICAL:** Allogenic islet cells (human, U. Chicago)
- **PROCEDURE:** Intraportal infusion of islet cells

## Key facts

- **NCT ID:** NCT01241864
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2010-12
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01241864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01241864, "Islet Transplantation in Type 1 Diabetic Kidney Allograft". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01241864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*